PHAI Submits Comments to FDA Supporting Reducing Nicotine Levels of Smoked Tobacco Products to Non-Addictive Levels

In response to a request for comments, PHAI urges the FDA to prioritize smoked tobacco nicotine reduction as a potentially highly effective tool to mitigate the public health cost of smoking. Please see our complete Comments (pdf).